Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJun 29, 2016VERMOX Tablets 100 mgCGMP DeviationsProfarma Distributors LLC · D-1041-2016Class IITerminatedJun 29, 2016tabcin NOCHECGMP DeviationsProfarma Distributors LLC · D-1040-2016Class IITerminatedJun 29, 2016tabcin ACTIVE M.R. CapsulesCGMP DeviationsProfarma Distributors LLC · D-1039-2016Class IIITerminatedJun 22, 2016Pramipexole Dihydrochloride Extended Release TabletsFailed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product...Par Pharmaceutical · D-1038-2016Class IITerminatedJun 22, 2016Sensorcaine- MPFPresence of Particulate Matter: Glass particulate found in sterile injectable productFresenius Kabi USA, LLC · D-1037-2016Class IIITerminatedJun 22, 2016Lisinopril Tablets USPLabeling: Incorrect or Missing Package InsertSandoz Inc · D-1036-2016Class IIITerminatedJun 22, 2016Chlordiazepoxide HCl/Clidinium Bromide capsulesFailed Impurities/Degradation SpecificationsValeant Pharmaceuticals North America LLC · D-1035-2016Class IIITerminatedJun 22, 2016Librax (5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide) capsulesFailed Impurities/Degradation SpecificationsValeant Pharmaceuticals North America LLC · D-1034-2016Class IITerminatedJun 22, 2016Vancomycin Hydrochloride for InjectionPresence of Particulate Matter: CardboardHospira Inc. · D-1033-2016Class IIITerminatedJun 22, 2016Lodrane DLabeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather...Valeant Pharmaceuticals North America LLC · D-1032-2016Class IIITerminatedJun 22, 2016DoxycyclineLabeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.Galderma Laboratories, L.P. · D-1031-2016Class IITerminatedJun 22, 2016Nitrofurantoin Oral SuspensionFailed Dissolution SpecificationsNostrum Laboratories, Inc. · D-1030-2016Class IIITerminatedJun 22, 2016HectorolLabeling: Wrong barcode. An incorrect bar code was noted on the vial label of Hectorol 2 mcg/1mL vial.Genzyme Corporation / Genzyme Biosurgery · D-1029-2016Class IITerminatedJun 15, 2016ITRACONAZOLE 0.2%/MUPIROCIN 0.2%/TRIAMCINOLONE 0.03% NASAL SPRAYLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1028-2016Class IITerminatedJun 15, 2016ITRACONAZOLE 0.2%/MUPIROCIN 0.2% NASAL SPRAYLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1027-2016Class IITerminatedJun 15, 2016CLOTRIMAZOLE 1%/ BETAMETHASONE DIPROPIONATE 0.05% OTIC SOLUTIONLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1026-2016Class IITerminatedJun 15, 2016QUAD-MIX #3Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1025-2016Class IITerminatedJun 15, 2016VITAMIN B COMPLEX # 3Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1024-2016Class IITerminatedJun 15, 2016VITAMIN B COMPLEX # 1Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1023-2016Class IITerminatedJun 15, 2016VANCOMYCIN 50MG/ML OPHTH SOLUTIONLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1022-2016Class IITerminatedJun 15, 2016TRI-MIX # 6Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1021-2016Class IITerminatedJun 15, 2016TRI-MIX # 5Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1020-2016Class IITerminatedJun 15, 2016TRI-MIX # 4Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1019-2016Class IITerminatedJun 15, 2016TRI-MIX # 3Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1018-2016Class IITerminatedJun 15, 2016TRI-MIX # 2Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1017-2016Class IITerminatedJun 15, 2016TRI-MIX # 1Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1016-2016Class IITerminatedJun 15, 2016TESTOSTERONE CYPIONATE 200MG/MLLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1015-2016Class IITerminatedJun 15, 2016TESTOSTERONE CYPIONATE 175MG/MLLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1014-2016Class IITerminatedJun 15, 2016TESTOSTERONE CYPIONATE 150MG/MLLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1013-2016Class IITerminatedJun 15, 2016TESTOSTERONE CYPIONATE 10MG/MLLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1012-2016Class IITerminatedJun 15, 2016TESTOSTERONE CYPIONATE 100MG/MLLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1011-2016Class IITerminatedJun 15, 2016SUPER TRI-MIX #4Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1010-2016Class IITerminatedJun 15, 2016SUPER TRI-MIX #1Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1009-2016Class IITerminatedJun 15, 2016QUAD-MIX #4Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1008-2016Class IITerminatedJun 15, 2016QUAD-MIX #2Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1007-2016Class IITerminatedJun 15, 2016QUAD-MIX #1Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1006-2016Class IITerminatedJun 15, 2016PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID- 5%/4.75%Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1005-2016Class IITerminatedJun 15, 2016PHENYLEPHERINE 0.5%Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1004-2016Class IITerminatedJun 15, 2016MYERS' COCKTAILLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1003-2016Class IITerminatedJun 15, 2016METHYLCOBALAMIN/FOLIC ACIDLack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.Well Care Compounding Pharmacy · D-1002-2016

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.